Manulife (Manufacturers Life Insurance)
SNDX icon

Manulife (Manufacturers Life Insurance)’s Syndax Pharmaceuticals SNDX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$932K Buy
39,904
+14,443
+57% +$314K ﹤0.01% 1867
2025
Q4 		$535K Sell
25,461
-3,303
-11% -$57.6K ﹤0.01% 2149
2025
Q3 		$443K Sell
28,764
-15,385
-35% -$201K ﹤0.01% 2260
2025
Q2 		$413K Buy
44,149
+2,479
+6% +$27.3K ﹤0.01% 2253
2025
Q1 		$512K Sell
41,670
-1,220
-3% -$17.2K ﹤0.01% 2131
2024
Q4 		$567K Sell
42,890
-4,814
-10% -$82.4K ﹤0.01% 2181
2024
Q3 		$918K Sell
47,704
-964
-2% -$19.9K ﹤0.01% 1966
2024
Q2 		$999K Buy
48,668
+6,755
+16% +$141K ﹤0.01% 1863
2024
Q1 		$998K Buy
41,913
+7,989
+24% +$178K ﹤0.01% 1861
2023
Q4 		$733K Sell
33,924
-214
-0.6% -$3.29K ﹤0.01% 1982
2023
Q3 		$496K Buy
34,138
+7,518
+28% +$142K ﹤0.01% 2148
2023
Q2 		$557K Buy
26,620
+5,010
+23% +$104K ﹤0.01% 1972
2023
Q1 		$456K Buy
21,610
+1,059
+5% +$26.3K ﹤0.01% 2062
2022
Q4 		$523K Buy
20,551
+517
+3% +$12.1K ﹤0.01% 1959
2022
Q3 		$481K Sell
20,034
-401
-2% -$9K ﹤0.01% 2007
2022
Q2 		$393K Buy
20,435
+1,138
+6% +$19K ﹤0.01% 2207
2022
Q1 		$335K Sell
19,297
-3,959
-17% -$66.7K ﹤0.01% 2446
2021
Q4 		$509 Sell
23,256
-628
-3% -$11.6K ﹤0.01% 2244
2021
Q3 		$456K Sell
23,884
-1,686
-7% -$28.1K ﹤0.01% 2358
2021
Q2 		$439K Buy
25,570
+7,563
+42% +$139K ﹤0.01% 2529
2021
Q1 		$403K Buy
18,007
+1,370
+8% +$31K ﹤0.01% 2428
2020
Q4 		$370K Buy
16,637
+246
+2% +$5.1K ﹤0.01% 2392
2020
Q3 		$242K Hold
16,391
– – ﹤0.01% 2447
2020
Q2 		$237K Buy
16,391
+1,956
+14% +$29.8K ﹤0.01% 2412
2020
Q1 		$158K Buy
14,435
+1,221
+9% +$11.5K ﹤0.01% 2424
2019
Q4 		$116K Sell
13,214
-1,407
-10% -$10.3K ﹤0.01% 2764
2019
Q3 		$113K Hold
14,621
– – ﹤0.01% 2798
2019
Q2 		$136K Buy
+14,621
New +$107K ﹤0.01% 2808
2018
Q3 		– Sell
-723
Closed -$5K – 3767
2018
Q2 		$5K Sell
723
-9,843
-93% -$96.6K ﹤0.01% 4086
2018
Q1 		$151K Buy
10,566
+7,686
+267% +$81.6K ﹤0.01% 3226
2017
Q4 		$25K Buy
2,880
+2,156
+298% +$21.3K ﹤0.01% 3740
2017
Q3 		$8K Buy
724
+630
+670% +$7.72K ﹤0.01% 3911
2017
Q2 		$1K Sell
94
-3
-3% -$34 ﹤0.01% 4251
2017
Q1 		$1K Hold
97
– – ﹤0.01% 4072
2016
Q4 		$1K Buy
+97
New +$1.06K ﹤0.01% 4221

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s SNDX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Syndax Pharmaceuticals (SNDX) stake by 57% in Q1 2026, buying an estimated $314K and bringing the position to 39,904 shares worth $932K. The position accounts for ﹤0.01% of the portfolio, ranked #1867.

Manulife (Manufacturers Life Insurance) first reported a position in SNDX in Q4 2016 and has held it in 35 quarters since. The position peaked at $999K in Q2 2024. 247 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 39,904 shares of Syndax Pharmaceuticals worth $932K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 14,443 Syndax Pharmaceuticals shares in Q1 2026, an estimated $314K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1867 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Syndax Pharmaceuticals in Q4 2016 and has held it in 35 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Syndax Pharmaceuticals position peaked at $999K in Q2 2024.
  • 247 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.